Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences High-Content and Phenotypic Screening 2020

Terry Riss's Biography



Terry Riss, Global Strategic Marketing Manager Cell Health, Promega Corporation

Dr. Riss received a PhD in Cell Biology from the University of Illinois in 1978 in the field of mammary gland biology. He did postdoctoral work at the University of Texas Medical School developing bioassays to study breast cancer. Dr. Riss moved to the Biotechnology division of Schering Plough in 1988 to develop interleukin/cytokine bioassays to support IND filings. Dr. Terry Riss started the Cell Biology program at Promega Corporation in 1990 where he has held several R&D and Project Management positions. Dr. Riss managed development of cell viability, cytotoxicity, apoptosis, and protease assay systems and lead efforts to promote multiplexing of cell-based assays to determine the mechanism of cell death. Dr. Riss now serves as Global Strategic Manager, Cell Health involved in outreach educational training activities. Dr. Riss serves as a co-editor of the NIH Assay Guidance Manual.

Terry Riss Image

Agenda is not currently available
Add to Calendar ▼2020-03-25 00:00:002020-03-26 00:00:00Europe/LondonHigh-Content and Phenotypic Screening 2020High-Content and Phenotypic Screening 2020 in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com